Ebola: Japan May Offer Unapproved Drug

Whatsapp News

Japan May Offer Unapproved DrugJapan would like to offer a drug to help treat the deadly virus before the World Health Organization officially rules on its use, the country’s top government spokesman said on Monday.

Chief Cabinet Secretary ,Yoshihide Suga, told a news conference Japan has received inquiries from some countries on the influenza drug, Favipiravir, or T-705, as it is known in the developmental code.

“I am informed that medical professionals could make a request for T-705 in an emergency even before a decision (on approval) by the WHO. In that case, we would like to respond under certain criteria,” he said.
Japan’s Fujifilm Holdings Corp and .S. Partner, MediVector, are in talks the U.S. and Drug Administration to submit an application to expand the use of Favipiravir as a treatment for Ebola.

Following Suga’s comments, Fujifilm shares rose 4.0 percent, edging near a four-year peak hit earlier in the month. They were the eighth most actively traded shares on the Tokyo Stock Exchange’s main board.

The Ebola epidemic in West Africa has more than 1,000 and prompted the WHO to declare an international health emergency.[eap_ad_3]